Drug regimes for acute cardiogenic pulmonary oedema
Thursday, January 1, 2009
Cardiovascular disease management has met with success through programmes such as the National Service Framework for Coronary Heart Disease. However, this has led to increased survival and therefore higher prevalence of patients living with impaired cardiac function. Acute cardiogenic pulmonary oedema (ACPO) is one of a number of distinct clinical conditions that result from abnormal cardiac function, primarily referred to as acute heart failure. This article will review current evidence-based pharmacological management of ACPO and make recommendations for future practice in prehospital care. Current drugs used in both prehospital and emergency care will be analysed for safety and efficacy in the management of ACPO.
Subscribe to get full access to the Journal of Paramedic Practice
Thank you for vising the Journal of Paramedic Practice and reading our archive of expert clinical content. If you would like to read more from the only journal dedicated to those working in emergency care, you can start your subscription today for just £48.
Reading the Journal of Paramedic Practice counts towards your professional development
Develop your career
We provide professional information dedicated to paramedics covering training, education and jobs
Get the latest clinical information to ensure you are aware of the latest think and best practice in paramedicne
Already registered? - Sign in here